Tafazzin rabbit pAb
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008],
Product Specifications
Background
UniProt
Q16635
Swiss Prot
Q16635
Reactivity
Human; Rat; Mouse
Immunogen
Synthesized peptide derived from the Internal region of human Tafazzin.
Clonality
Polyclonal
Source
Rabbit
Applications
WB; ELISA
Concentration
1 mg/ml
Dilution
Western Blot: 1/500 - 1/2000. ELISA: 1/5000. Not yet tested in other applications.
Molecular Weight
33kD
Storage Conditions
-20°C/1 year
Observed Molecular Weight
33kD
Fragment
IgG
Subcellular Location
Other Product Names
TAZ; EFE2; G4.5; Tafazzin; Protein G4.5
Gene ID (Human)
6901
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items